期刊文献+

胸部肿瘤病人放疗中血清心肌酶学的变化 被引量:1

Changes of Serum Myocardiac Enzymology for Patients with Radiotherapy on Chest
下载PDF
导出
摘要 目的:观察心肌受照射面积及照射剂量对血清心肌酶学改变的影响。方法:对86例射野累及心脏的肺癌和食管癌病人行60Co线照射,并在照射前、照射中和照射结束时检测血清LDH、AST、CK及CK-MB浓度的改变,同时行心电图检查。结果:①血清LDH及AST浓度无显著改变。②血清CK浓度在心脏受照射面积占心脏面积50%以上,且照射剂量高于60Gy时出现升高。③血清CK-MB浓度在心脏受照射面积占心脏面积50%以上时出现升高。④有2例患者心电图出现ST段改变,占全部病例的2.3%。结论:血清CK浓度的改变与心脏受照射面积及照射剂量相关,血清CK-MB浓度的改变仅与心脏受照射面积相关。 Objective: Our aim was to study the influence of radiotherapy area and dose of the heart on serum myocardiac enzymology for the patients received radiotherapy on chest. Methods: Eightysix patients with lung cancer or esophagus cancer were irradiated with 60Co ray and the radioactive region involved the patientsheart. The values of the LDH, AST, CK and CKMB in the serum were measured before irradiation, in the middle of irradiation, and at the end of irradiation, respectively. ECG was examined at the same time. Results: The values of the LDH and AST in the serum did not change obviously. The value of CK increased when more than 50% area of the heart was irradiated and dose were more than 60 Gy. When the irradiation area were more than 50%, the value of the CKMB increased, too. The ST segment in the electrocardiogram for 2 patients (2.3%) showed changes ofter radiotherapy. Conclusion: The change of the CK in the serum was related to radioactive area of the heart and dose. The change of CKMB was related only to radioactive area.
出处 《中国医科大学学报》 CAS CSCD 北大核心 1999年第3期213-214,共2页 Journal of China Medical University
关键词 胸部肿瘤 放射疗法 心肌酶学 thoracic neoplasms radiotherapy myocardiac enzymology
  • 相关文献

参考文献2

  • 1白蕴红,解放军医学情报,1994年,8卷,184页
  • 2周桂霞,中华放射肿瘤学杂志,1993年,2卷,119页

同被引文献11

  • 1Boivin JF, Hutchison GB, Lubin JH, et al. Coronary artery disease mortality in patients treated for Hodgkin' s disease. Cancer, 1992,69 : 1241-1247.
  • 2Gaya AM, Ashford RF. Cardiac complications of radiation therapy. Clin Oncol,2005,17 : 153-159.
  • 3Zambetti M, Moliterni A, Materazzo C, et al. Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation. J Clin Oncol,2001,19 :37-43.
  • 4Hardenbergh PH, Munley MT, Bentel GC, et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin:preliminary results. Int J Radiat Oneol Biol Phys,2001,49 :1023-1028.
  • 5Vallis KA, pintilie M, Chong N, et al. Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. J Clin Oncol,2002,20:1036-1042.
  • 6Muren LP, Maurstad, Hafslund R, et al. Cardiac and pulmonary doses and complication probabiolities in standard and conformal tangential irradiation in conservstive management of breast cancer. Radiother Oncol.2002.62 : 173-183.
  • 7Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys, 1991,21 : 109-122.
  • 8Krayenbuehl J, Oertel S, Davis JB, et al. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy. Int J Radiat Oncol Biol Phys ,2007,69:1593-1599.
  • 9Lagrange JL, Darcourt J, Benoliel J, et al. Acute cardiac effects of mediastinal irradiation : assessment by radionuclide angiography. Int J Radiat Oncol Biol Phvs, 1992.22 : 897-903.
  • 10El-Awady, El-SE, Moustafa YM, et al. Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies. Eur J Pharmacol,2011,650:335-341.

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部